Pacific Hospital Supply Co., Ltd.was founded on August 6, 1977. Its main Business include the manufacturing, processing and trading of all kinds of medical equipments; the construction, installation, manufacturing and trading of medical gas piping and equipments; and others. Tongluo supplies factory was established in 1985 and began production of plastic consumables. Tongluo Equipment Factory was established in 2000. In 2001 Securities and Futures Commission Ministry of Finance approved its public offering of stock, and Tongluo supplies factory obtained ISO9001 and CE certification. In 2002 Tongluo supplies factory obtained GMP certification; and Tongluo Equipment Factory obtained ISO9001 certification. In the same year of 2002, it applied to the Foundation of the Republic of China Securities for OTC stocks. In 2003 Tongluo Equipment Factory obtained GMP certification.
Basic Information
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
President
Purchase this report to view the information.
Spokesperson
Ownership Details
Purchase this report to view the information.
6.49%
Purchase this report to view the information.
2.69%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Pasco Medical Technology (Changzhou)
Company Performance
Financial values in the chart are available after Pacific Hospital Supply Co., Ltd. report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.27%▼
Total operating revenue
-14.27%▼
Operating profit (EBIT)
-51.5%▼
Net Profit (Loss) for the Period
-34.93%▼
Operating Profit Margin (ROS)
-8.61%▼
Net Profit Margin
-3.59%▼
Return on Equity (ROE)
-1.16%▼
Debt to Equity Ratio
-4.58%▼